J Knee Surg 2011; 24(3): 197-202
DOI: 10.1055/s-0031-1280881
ORIGINAL ARTICLE

© Thieme Medical Publishers

Percutaneous Neuromodulation Pain Therapy Following Knee Replacement

Tony Wanich1 , Jonathan Gelber2 , Scott Rodeo2 , Russell Windsor2
  • 1Department of Orthopaedics, Montefiore Medical Center, Bronx, New York
  • 2Hospital for Special Surgery, New York, New York
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. Juni 2011 (online)

Preview

ABSTRACT

A new device (Deepwave®) utilizing percutaneous neuromodulation technology has been developed with preliminary studies demonstrating superior pain inhibition compared with transcutaneous electrical nerve stimulation. We hypothesize that the use of Deepwave is efficacious in reducing the severity of acute pain and opioid use in patients following total knee replacement (TKR) surgery. We conducted a randomized controlled trial on 23 patients who underwent primary TKR. The patients were categorized into two groups—experimental or control group. Following TKR, patients underwent either Deepwave or sham treatments. A Brief Pain Inventory questionnaire and the amount of all pain medications taken were recorded. There was a significant reduction in patient's subjective rating of pain and Visual Analog Scale score in the experimental group (p < 0.05), with a trend toward decreased opioid use but this was not significant (p = 0.09) The Deepwave device is effective in reducing the subjective measures of pain with a trend toward decreased opioid use in patients following TKR.

REFERENCES

Tony WanichM.D. 

Department of Orthopaedics, Montefiore Medical Center

1250 Waters Place, 11th Floor, Bronx, NY 10461

eMail: twanich@montefiore.org